Molecular Partners AG
- Last sale
- Nov 5, 2026 · +0.58%
- Market cap
- $139.70M
- 40.37M shares
- Filings
- 121
FY 2025−100.0% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+29.4% FY25 yoy
- $139.70M
- —
- —
- —
- —
- —
Price
Nov 5, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | CHF 0 | reported | |
| FY 2024 | 2024-12-31 | CHF 4,970,000 | reported | |
| FY 2023 | 2023-12-31 | CHF 7,038,000 | reported | |
| FY 2022 | 2022-12-31 | CHF 189,600,000 | reported | |
| FY 2021 | 2021-12-31 | CHF 9,754,000 | reported | |
| FY 2020 | 2020-12-31 | CHF 9,344,000 | reported | |
| FY 2019 | 2019-12-31 | CHF 20,383,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | CHF 0.00 | CHF 0.00 | — | 40.36M sh | +11.0% | — |
| FY2023 | — | CHF 0.00 | CHF 0.00 | — | 36.35M sh | +0.9% | — |
| FY2022 | — | CHF 631.00K | CHF 631.00K | — | 36.04M sh | +11.6% | 0.5% |
| FY2021 | — | CHF 0.00 | CHF 0.00 | — | 32.29M sh | — | — |
| FY2020 | — | CHF 0.00 | CHF 0.00 | — | — | — | — |
Biological products, except diagnostic substances
Molecular Partners AG is the 105th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
FATEFate Therapeutics Inc$6.6M51.2%2,051.1%$161.7MSTROSutro Biopharma, Inc.$102.5M65.2%186.5%$159.0MENGNenGene Therapeutics Inc.———$153.5MCMPXCompass Therapeutics, Inc.$0.0100.0%—$147.1MTARAProtara Therapeutics, Inc.———$143.0MARMPArmata Pharmaceuticals, Inc.———$141.3MIPHAInnate Pharma SA———$140.6M
MOLNMolecular Partners AG (this company)———$139.7M
LENZLENZ Therapeutics, Inc.$19.1M—430.3%$127.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Molecular Partners AG · CIK 1745114 · Engraved from SEC EDGAR